PaxMedica, Inc. Common Stock
PXMD · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $1,608 | $4,072 | $5,603 | $4,723 |
| - Cash | $324 | $1,627 | $4,711 | $1,153 |
| + Debt | $0 | $0 | $0 | $1,581 |
| Enterprise Value | $1,283 | $2,446 | $892 | $5,151 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,998 | -$3,693 | -$5,920 | -$5,048 |
| % Margin | – | – | – | – |
| Net Income | -$2,998 | -$3,693 | -$5,920 | -$5,049 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.39 | -0.5 | -0.8 | -5.2 |
| % Growth | 22% | 37.5% | 84.6% | – |
| Operating Cash Flow | -$1,302 | -$3,068 | -$2,617 | -$2,332 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,302 | -$3,068 | -$2,617 | -$2,332 |